Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
3.490
-0.210 (-5.68%)
May 15, 2026, 4:00 PM EDT - Market closed
AKTX's stock price has decreased by -93.54% in the past year and price targets may not have had time to catch up.

Akari Therapeutics, Analyst Ratings

Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$33.50
Upside
+859.89%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Hold
Downgrades
n/a
HoldDowngradesn/an/aApr 8, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$1.6$27
Strong BuyMaintains$1.6$27+673.64%Apr 1, 2026
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Initiates
$40
Strong BuyInitiates$40+1,046.13%Jan 5, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$64
Strong BuyReiterates$64+1,733.81%Sep 9, 2025
Maxim Group
Maxim Group
Strong Buy
Initiates
$200
Strong BuyInitiates$200+5,630.66%Jul 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$1,200
Strong BuyInitiates$1,200+34,283.95%Dec 5, 2022
Alliance Global Partners
Alliance Global Partners
Strong Buy
Initiates
$3,200
Strong BuyInitiates$3,200+91,590.54%Nov 1, 2022
B. Riley Securities
B. Riley Securities
Strong Buy
Maintains
$5,600$4,000
Strong BuyMaintains$5,600$4,000+114,513.18%Mar 13, 2020
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$12,000$6,400
Strong BuyMaintains$12,000$6,400+183,281.09%Mar 29, 2018
B. Riley Securities
B. Riley Securities
Hold
Initiates
$2,400
HoldInitiates$2,400+68,667.91%Feb 8, 2018
William Blair
William Blair
Buy
Upgrades
n/a
BuyUpgradesn/an/aSep 22, 2017
Chardan Capital
Chardan Capital
Hold
Upgrades
n/a
HoldUpgradesn/an/aMay 31, 2017
William Blair
William Blair
Hold
Downgrades
n/a
HoldDowngradesn/an/aMay 12, 2017
Chardan Capital
Chardan Capital
Strong Sell
Reiterates
$4,000$5,200
Strong SellReiterates$4,000$5,200+148,897.13%Apr 17, 2017
Chardan Capital
Chardan Capital
Strong Sell
Initiates
$4,000
Strong SellInitiates$4,000+114,513.18%Jul 11, 2016